Our results suggest that silencing ASIC3 interrupts the pro-inflammatory signaling loop between neural and immune systems, providing evidence for a potential neuroimmune strategy to treat psoriasis and other cutaneous inflammatory diseases. Here, ASIC3 is linked to psoriasis.